Lora Yeager-Smith, DPM
Podiatrist · Escondido, CANPI 1811939176
Payments from drug & device makers
Across 30 payments — averaging $72.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$2K
- Alafair Biosciences, Inc.$177
- Comsort, Inc$100
- Stryker$72
- AbbVie$55
- Organogenesis Inc.$50
- plus $179 from 8 others
What the payments were for
- Consulting fees$1005%
- Travel & lodging$1,18954%
- Food & beverage$90041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 10 | $1,555 |
| Alafair Biosciences, Inc. | 2 | $177 |
| Comsort, Inc | 1 | $100 |
| Stryker | 3 | $72 |
| AbbVie | 2 | $55 |
| Organogenesis Inc. | 3 | $50 |
| Paragon 28, Inc. | 1 | $50 |
| Amgen | 1 | $29 |
| Paratek Pharmaceuticals, Inc. | 2 | $26 |
| Melinta Therapeutics, LLC | 1 | $25 |
| Averitas Pharma Inc. | 1 | $17 |
| Smith+Nephew | 1 | $16 |
| Globus Medical | 1 | $16 |
| Triad Life Sciences Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,189 in reported general payments places this provider in the 65th percentile of 721 podiatrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 38 | $1,346 |
| Ammonium Lactate | 52 | $1,245 |
| Ketoconazole | 37 | $922 |
| Cephalexin | 32 | $283 |
| Gabapentin | 23 | $225 |
| Terbinafine Hcl | 12 | $182 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Escondido
- Fardin HakakianTarzana$2.8M
- David GuzmanNapa$2.1M
- Shannon RushPleasanton$1.9M
- Babak BaravarianSanta Monica$1.6M
- David ArmstrongLos Angeles$1.4M
- Dean VayserCarlsbad$1.2M
- Robert KleimanCalexico$913K
- Bruce LawrenceOceanside$810K
- Shawn CazzellFresno$788K
- Philip WrotslavskyPoway$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.